Figure 2From: High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients Kaplan-Meier actuarial analysis of all 351 patients for: (a) Biochemical control, overall survival and metastasis-free survival and (b) Biochemical control by risk group. Back to article page